Finally, we aimed to validate our findings in the ECLIPSE study by testing the association between the two gene signatures and FEV1 measurements at baseline and follow-up visits, FEV1 decline, exacerbation frequency, percent emphysema, and Pi10. This evidence concerns the gene SERPINB10 and pulmonary emphysema.